205 related articles for article (PubMed ID: 11034402)
1. Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo.
Chroneos ZC; Wert SE; Livingston JL; Hassett DJ; Whitsett JA
J Immunol; 2000 Oct; 165(7):3941-50. PubMed ID: 11034402
[TBL] [Abstract][Full Text] [Related]
2. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
[TBL] [Abstract][Full Text] [Related]
3. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
Yu H; Nasr SZ; Deretic V
Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
[TBL] [Abstract][Full Text] [Related]
4. Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic mice.
Whitsett JA; Dey CR; Stripp BR; Wikenheiser KA; Clark JC; Wert SE; Gregory RJ; Smith AE; Cohn JA; Wilson JM
Nat Genet; 1992 Sep; 2(1):13-20. PubMed ID: 1284640
[TBL] [Abstract][Full Text] [Related]
5. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection.
LeVine AM; Kurak KE; Bruno MD; Stark JM; Whitsett JA; Korfhagen TR
Am J Respir Cell Mol Biol; 1998 Oct; 19(4):700-8. PubMed ID: 9761768
[TBL] [Abstract][Full Text] [Related]
6. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.
van Heeckeren AM; Schluchter MD; Xue W; Davis PB
Am J Respir Crit Care Med; 2006 Feb; 173(3):288-96. PubMed ID: 16272448
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation.
Ortiz-Muñoz G; Yu MA; Lefrançais E; Mallavia B; Valet C; Tian JJ; Ranucci S; Wang KM; Liu Z; Kwaan N; Dawson D; Kleinhenz ME; Khasawneh FT; Haggie PM; Verkman AS; Looney MR
J Clin Invest; 2020 Apr; 130(4):2041-2053. PubMed ID: 31961827
[TBL] [Abstract][Full Text] [Related]
8. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB
Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089
[TBL] [Abstract][Full Text] [Related]
9. Gene complementation of airway epithelium in the cystic fibrosis mouse is necessary and sufficient to correct the pathogen clearance and inflammatory abnormalities.
Oceandy D; McMorran BJ; Smith SN; Schreiber R; Kunzelmann K; Alton EW; Hume DA; Wainwright BJ
Hum Mol Genet; 2002 May; 11(9):1059-67. PubMed ID: 11978765
[TBL] [Abstract][Full Text] [Related]
10. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
[TBL] [Abstract][Full Text] [Related]
11. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
Pier GB; Grout M; Zaidi TS; Olsen JC; Johnson LG; Yankaskas JR; Goldberg JB
Science; 1996 Jan; 271(5245):64-7. PubMed ID: 8539601
[TBL] [Abstract][Full Text] [Related]
12. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.
Pier GB; Grout M; Zaidi TS; Goldberg JB
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538
[TBL] [Abstract][Full Text] [Related]
13. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.
Van Heeckeren AM; Scaria A; Schluchter MD; Ferkol TW; Wadsworth S; Davis PB
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L717-26. PubMed ID: 14514520
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L43-9. PubMed ID: 24097557
[TBL] [Abstract][Full Text] [Related]
15. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections.
Pier GB
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8822-8. PubMed ID: 10922041
[TBL] [Abstract][Full Text] [Related]
16. A BAC Transgene Expressing Human CFTR under Control of Its Regulatory Elements Rescues Cftr Knockout Mice.
Gawenis LR; Hodges CA; McHugh DR; Valerio DM; Miron A; Cotton CU; Liu J; Walker NM; Strubberg AM; Gillen AE; Mutolo MJ; Kotzamanis G; Bosch J; Harris A; Drumm ML; Clarke LL
Sci Rep; 2019 Aug; 9(1):11828. PubMed ID: 31413336
[TBL] [Abstract][Full Text] [Related]
17. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.
Boucher JC; Yu H; Mudd MH; Deretic V
Infect Immun; 1997 Sep; 65(9):3838-46. PubMed ID: 9284161
[TBL] [Abstract][Full Text] [Related]
18. Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells.
Reiniger N; Ichikawa JK; Pier GB
Infect Immun; 2005 Oct; 73(10):6822-30. PubMed ID: 16177360
[TBL] [Abstract][Full Text] [Related]
19. Lung arginase expression and activity is increased in cystic fibrosis mouse models.
Jaecklin T; Duerr J; Huang H; Rafii M; Bear CE; Ratjen F; Pencharz P; Kavanagh BP; Mall MA; Grasemann H
J Appl Physiol (1985); 2014 Aug; 117(3):284-8. PubMed ID: 24925982
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator.
Cannon CL; Kowalski MP; Stopak KS; Pier GB
Am J Respir Cell Mol Biol; 2003 Aug; 29(2):188-97. PubMed ID: 12878584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
